Dear Friends
In this ongoing post we will maintain a list of Clinical Trial companies with their websites
Accutest Research Laboratories http://www.accutestindia.com/
Dr Sahoos Clinical Services Pvt Ltd http://www.drsahoo.com/
Bio-Scientific Research Laboratories (I) Pvt Ltd email: biosrl@vsnl.net
Accutest Research Laboratories (I) Pvt. Ltd.
Ace Biomed Pvt. Ltd.
Adroit Insights Lifesciences Pvt. Ltd.
Apothecaries Ltd.
Asian Clinical Trials Pvt. Ltd.
Catalyst Clinical Services Pvt. Ltd.
Clinigene International Pvt. Ltd.
ClinInvent Research Pvt. Ltd.
ClinTec International Ltd.
Clintrac International Pvt. Ltd.
ClinWorld Pvt. Ltd.
Covance Inc.
Diagno-search (taken over by iGATE)
ICON Plc
iGATE Clinical Research International Pvt. Ltd.
Jubilant Clinsys Ltd.
Kendle International Inc.
Lambda Therapeutic Research Ltd.
Lotus Labs Pvt. Ltd.
Manipal Acunova Ltd.
Materiamedica Services Pvt. Ltd.
Neeman Medical International
Omnicare Clinical Research
Parexel International
Pharmaceutical Product Development, Inc.
Pharmanet Development Group, Inc.
Quintiles Spectral Ltd.
Reliance Clinical Research Services Pvt. Ltd.
Sipra Labs Pvt. Ltd.
SIRO Clinpharm Pvt. Ltd.
Suven Life Sciences Ltd.
Synchron Research Services Pvt. Ltd.
Vibgyor Care http://www.vibgyorcare.com/
Veeda Clinical Research Ltd.
Vimta Labs Ltd.
Wellquest International (India)
The above list will be updated on a periodic basis. For a detailed list you can obtain BII's free clinical trial directory be sending us an email at members@bioinformaticscentre.org
For BII's Clinical Trial Program you can visit www.bii.in/biodlp
For BII Admin
Subscribe to:
Post Comments (Atom)
3 comments:
Recently I read an interesting new release that an innovative oral insulin drug was approved in India. Toronto located Generex's Oral-lyn (http://www.generex.com/ ) became the first non-injectable buccal insulin approved in India. Apparently Oral insulin is delivered to the mouth via buccal membranes and unlike inhaled insulin products, buccally absorbed Oral Insulin does not reach the lungs.
This is an interesting strategy for development stage pharmaceutical and biopharmaceutical companies in the US. Getting the product approved in a big country like China or India could help better understand the product performance in real patients much before going to FDA or EMEA who in anyway would take years and tons of data to approve. This strategy might help earn licensing revenue early and to raise funding pipeline. Further it appears there are firms (http://www.nectidindia.com/) who focus exclusively on providing such narrow services. Interesting!!!
PharmaBlog
Oral insulin should be brought to the market immediately at least in India. As insulin in blood is already a time tested affair and it has proved to be non harmful, releasing oral insulin after brief clinical trails is quite wise. Moreover, in countries like equador it is already being used for at least over a year and serious side effects if any would have surfaced by now. In releasing a new drug in to the market always an elemental risk is involved which obviously cannot be avoided. There may be instances where Even drugs approved by FDA after careful study were withdrawn later due to bad effects. Riddance of human sufferring is most important and undue delays in clinical trials are killing the hopes of patients. Many sufferres of diabetes like me feel that in any case the disease cannot be stopped or its ill effects prevented and therefore taking a risky drug does not really matter!
Clinnovo Research Labs provides Internships, Trainings, Job Assistance in the Domains of Clinical Research, Clinical Data Management, SAS, Pharmacovigilance. For more details contact us @ +91-9985492233. www.clinnovo.com
clinical Research Training
clinical Research Training in hyderabad
Post a Comment